Current Clinical Pharmacology
Title:Meet Our Editorial Board Member
Volume: 11 Issue: 2
Author(s): Chim C. Lang
Affiliation:
Export Options
About this article
Cite this article as:
Lang C. Chim, Meet Our Editorial Board Member, Current Clinical Pharmacology 2016; 11 (2) . https://dx.doi.org/10.2174/157488471102160801180437
DOI https://dx.doi.org/10.2174/157488471102160801180437 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
36
Related Articles
-
Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Current Pharmaceutical Design The Noncoding Side of Cardiac Differentiation and Regeneration
Current Stem Cell Research & Therapy A Review of Voltammetric Methods for Determination of Dopamine Agonists
Current Analytical Chemistry Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology Oxidative Stress Biomarkers in Coronary Artery Disease
Current Topics in Medicinal Chemistry Autophagy and Mitochondria in Obesity and Type 2 Diabetes
Current Diabetes Reviews Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates
Current Pharmaceutical Design Importance of Assessing the Effect of Statins on the Function of High- Density Lipoproteins on Coronary Plaque
Cardiovascular & Hematological Disorders-Drug Targets Platelets as Potential Link Between Diabetes and Alzheimer's Disease
Current Alzheimer Research Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Bioactive Small Molecules in the Pathogenesis and Pharmacology of Cardiovascular Diseases: From Bench to Bedside
Current Topics in Medicinal Chemistry The Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure
Current Medicinal Chemistry Concepts for Nano-delivery of Therapeutic Immunomodulatory Agents
Current Bionanotechnology (Discontinued) Downregulation of Hepatic Carbonyl Reductase Type 1 in End-Stage Renal Disease
Drug Metabolism Letters Chronic Hypoxia Potentiates Age-Related Oxidative Imbalance in Brain Vessels and Synaptosomes
Current Neurovascular Research Editorial [Hot Topic: Oxidative Stress Induced-Metabolic Imbalance, Mitochondrial Failure, And Cellular Hypoperfusion As Primary Pathogenetic Factors For The Development Of Alzheimer Disease Which Can Be Used As An Alternate And Successful Drug Treatment Strategy: Past, Present And Future (Guest Editor: Gjumrakch Aliev)]
CNS & Neurological Disorders - Drug Targets Cholinesterase Inhibitors Slow Decline in Executive Functions, Rather than Memory, in Alzheimers Disease: A 1-Year Observational Study in the Sunnybrook Dementia Cohort
Current Alzheimer Research Lipid Lowering Therapy in the Elderly: Is there a Benefit?
Current Pharmaceutical Design Fenofibrate and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Heart Transplantation for Congenital Heart Disease in the First Year of Life
Current Cardiology Reviews